At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 10 enrolled
Drug / intervention
CRoC +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance of Junctional Tourniquets in Normal Human Volunteers
United States Army Institute of Surgical Research·interventional·Posted Oct 18, 2013·Updated Dec 13, 2017
In Brief
A Phase 4 clinical trial evaluating CRoC, AAJT, and 2 other interventions for Hemorrhage. Completed, enrolled 10 participants across 1 site.
Detailed Summary
Normal human adult volunteers wereused to investigate the performance of medical devices intended to stop junctional bleeding on the battlefield.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedOct 2013
Primary CompletionDec 2013
TodayJul 2026
First PostedOct 18, 2013
Enrollment StartOct 1, 2013
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 12.7 years ago
Interventions
CRoCdevice
Use of Combat Ready Clamp (CRoC)
AAJTdevice
Use of Abdominal Aortic and Junctional Tourniquet (AAJT)
JETTdevice
Use of Junctional Emergency Treatment Tool (JETT)
SJTdevice
Use of SAM Junctional Tourniquet (SJT)